COVID-19 first wave increased the sale of antibiotic formulations in India
The first wave of COVID-19 in 2020 in India saw a substantial increase in the sale of antibiotic formulations used in adults and adolescents, especially azithromycin, says a study.
COVID-19 likely contributed to about 216 million excess doses of non-paediatric formulations of antibiotics in total and 38 million excess doses of azithromycin between June and September 2020, says the study which looked at the private health care sector in India, and published this month in
PLOS Medicine.
Antibiotics are often used in viral infections (e.g. viral pneumonia) to combat possible bacterial co-infections. This is despite antibiotics being ineffective against viral infections, according to the US Centers for Disease Control and Prevention.
COVID-19 boosted excess sale of antibiotics in India
scidev.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scidev.net Daily Mail and Mail on Sunday newspapers.
16 kids undergoing treatment for Covid-19 in Puducherry
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.